deltatrials
Completed OBSERVATIONAL NCT05463276

The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study

Sponsor: Sindh Institute of Urology and Transplantation

Updated 3 times since 2022 Last updated: Jul 18, 2022 Started: Feb 28, 2022 Primary completion: May 1, 2022 Completion: May 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer and Breast Cancer Invasive and is currently completed. Sindh Institute of Urology and Transplantation leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

3 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Sep 2022 — Jul 2024 [monthly]

    Completed

    First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sindh Institute of Urology and Transplantation
Data source: Sindh Institute of Urology and Transplantation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations